Entities / Company
Fortress Biotech.
company
- Reports this week
- 0
- Active events
- 0
- Connections
- 26
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
MarketBeat is providing analyst recommendations for two small-cap medical companies, Fortress Biotech and bioAffinity Technologies.Some support1 report
-
Ultragenyx Pharmaceutical and Fortress Biotech are seeking FDA approval for gene therapy candidates.Some support1 report
-
Journey Medical Corporation, founded by Fortress Biotech, is located in Scottsdale and sells FDA-approved products while filing reports with the SEC.Well supported8 reports1 development inside
-
Fortress subsidiary Checkpoint Therapeutics was acquired by Sun Pharmaceutical.Some support1 report
-
Fortress Biotech underperformed the market so far this year as of August 15, 2025.Some support1 report
-
Fortress Biotech established partnerships with AstraZeneca and Fred Hutchinson Cancer Center.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Fortress Biotech this week
News at the entities that move Fortress Biotech most-
Citigroup TransactionalMarketBeat reported on the merger of thyssenkrupp AG and Thyssen AG, which is receiving analyst ratings and company data.Moves Fortress Biotech
-
MarketBeat Mentioned togetherJefferies Financial Group boosted its price objective for MMM, with MarketBeat aggregating the consensus data.Moves Fortress Biotech
Connections
The 4 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sun Pharmaceutical Structural
Fortress Biotech's subsidiary, Checkpoint Therapeutics, was acquired by Sun Pharmaceutical, establishing a structural relationship.
-
Fred Hutchinson Cancer Center Operational
Fortress Biotech and Fred Hutchinson Cancer Center have established partnerships.
-
MarketBeat Mentioned together
MarketBeat provides analyst recommendations and tracks the status of Fortress Biotech.
-
Citigroup Transactional
Citigroup issued and reaffirmed a 'buy' rating on the shares of Fortress Biotech.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
1 eventAugust 2026
1 eventShow 2 earlier months
July 2026
1 eventJune 2026
5 events- Ultragenyx Pharmaceutical and Fortress Biotech are seeking FDA approval for gene therapy candidates.
- Journey Medical Corporation, founded by Fortress Biotech, is located in Scottsdale and sells FDA-approved products while filing reports with the SEC.
- Fortress subsidiary Checkpoint Therapeutics was acquired by Sun Pharmaceutical.
- Fortress Biotech underperformed the market so far this year as of August 15, 2025.
- Fortress Biotech established partnerships with AstraZeneca and Fred Hutchinson Cancer Center.